Severe Sleep Apnea Linked to Increased Beta-Amyloid in Brain
The OSA group recorded a higher amyloid burden, poorer sleep efficiency, and less time spent in stage N3 sleep.
Read More
Author: Sree Roy
Expanded WAKIX Label Could ‘Help Even More People Living with Narcolepsy’
The FDA says that Harmony Biosciences’ drug—previously approved for excessive daytime sleepiness in narcolepsy—works for cataplexy too. Harmony’s chief medical officer explains how this impacts healthcare practitioners and patients.
Read MoreFirst Patient Dosed in Sleep Apnea Pill Phase 2 Clinical Trial
Apnimed’s AD109 is dosed once-daily at bedtime, designed to treat OSA patients across a broad spectrum of disease severity.
Read MoreThis Thanksgiving, It’s Time to Stop Nap-Shaming
Maybe in 2020 we can admit that the post-turkey crash is nothing to be ashamed of, reports The New York Times.
Read MoreFirst Patient Enrolls in Central Sleep Apnea Trial to Assess Alternative Transvenous Lead Location for Remedē Implant
The trial seeks to explore whether transvenous stimulation can improve airway physiology.
Read More